PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 201 filers reported holding PTC THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,045,000 | -9.3% | 22,347 | -1.6% | 0.00% | -25.0% |
| Q2 2020 | $1,152,000 | +4.5% | 22,702 | -8.1% | 0.00% | -42.9% |
| Q1 2020 | $1,102,000 | -79.4% | 24,701 | -77.8% | 0.01% | -74.1% |
| Q4 2019 | $5,346,000 | +66.5% | 111,302 | +17.2% | 0.03% | +35.0% |
| Q3 2019 | $3,211,000 | -23.9% | 94,930 | +1.2% | 0.02% | -28.6% |
| Q2 2019 | $4,220,000 | +15.3% | 93,775 | -3.6% | 0.03% | +33.3% |
| Q1 2019 | $3,660,000 | -50.5% | 97,243 | -54.9% | 0.02% | -55.3% |
| Q4 2018 | $7,395,000 | -20.7% | 215,452 | +8.6% | 0.05% | +17.5% |
| Q3 2018 | $9,323,000 | – | 198,351 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |